U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

In the global pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $7.5m, according to GlobalData's Deals Database.

John Graham, Group CEO of Zuellig Pharma, talks about election risks, US-China tensions, and how tariffs and protectionism ...

Serenity Healthcare is a leading healthcare organization in this space, offering insightful commentary on some of the ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

As the Minister said, the pharmaceutical industry, through research and innovation, becomes more competitive, more ...

In a significant financial move in the pharmaceutical industry, Edwards Life Sciences has sold its Critical Care division to Becton Dickinson (BD) for $4,200 million. The transaction, legally executed ...

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance on Wednesday after beating third-quarter profit ...

a leading industry group. That’s 25% larger than it was in 2019, making it bigger than the sports and pharmaceutical industries. “Growth was even stronger than we predicted,” says Katherine ...

In the global pharmaceutical industry, there were three private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.